Arrowhead Pharmaceuticals Inc — balance trimestral (NASDAQ:ARWR) | MetaTrader

Ver el calendario completo

Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Noticias

TD Cowen reitera calificación de Compra para Arrowhead Pharma

BofA recorta el precio objetivo de Arrowhead Pharma por perspectivas de obesidad

Wave Life Sciences Crashes 55% As 'Body Composition' Fat-Loss Drug Underwhelms

Arrowhead Pharmaceuticals: Transition Phase With Moderate Upside Ahead (NASDAQ:ARWR)

Leerink reitera calificación de acciones de Arrowhead Pharma tras datos de socio

Wolfe Research reitera calificación de acciones de Ionis por estrategia de precios

Sarepta Plans FDA Filings Seeking Full Approval for Two DMD Therapies

SRPT Stock Up as Enrollment Begins in DMD Gene Therapy Safety Study

Hamilton James, director médico de Arrowhead Pharmaceuticals, vende acciones por 641.900 dólares

CMO de Arrowhead Pharmaceuticals vende acciones por $641,900

Arrowhead Pharmaceuticals en la Conferencia Leerink: Perspectivas Estratégicas del Pipeline

Arrowhead Pharmaceuticals en Conferencia Leerink: Perspectivas Estratégicas